Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Microenvironment Immune Cells in Bone Marrow and Lymph Node Measured By Flow Cytometry Have Prognostic Impact on Survival in Nodal Non-Hodgkin T-Cell Lymphoma

Laura Korin, Maria Lucia Fuente, Santiago Cranco, Paola Ochoa, Adriana Vitriu, Evelina Babuin, Olivia Gelo, Luis Ayala, Paula Tempra, Andrea Novoa, Maria Belen Venegas, Anahí Vijnovich Baron, Maria Del Rosario Custidiano, Norma Elisabeth Tartas, Maria Cecilia Foncuberta, Julio Cesar Sanchez Avalos

Blood (2022) 140 (Supplement 1): 11936–11937.

https://doi.org/10.1182/blood-2022-167240

Published: 2022

Journal Articles

Low Percentage of Microenvironment Immune Cells in Bone Marrow and Lymph Node Measured By Flow Cytometry Is Associated with Inferior Overall Survival in Diffuse Large B Cell Lymphoma

Laura Korin, Maria Lucia Fuente, Santiago Cranco, Paola Ochoa, Adriana Vitriu, Evelina Babuin, Anahí Vijnovich Baron, Maria Belen Venegas, Paula Tempra, Andrea Novoa, Norma Elisabeth Tartas, Maria Del Rosario Custidiano, Maria Cecilia Foncuberta, Julio Cesar Sanchez Avalos

Blood (2021) 138 (Supplement 1): 2415.

https://doi.org/10.1182/blood-2021-150839

Published: 2021

Journal Articles

Bone Marrow Microenvironment Immune Cells Measured By Flow Cytometry Can Predict Survival and Identify a Subgroup in Risk of Early Relapse in Diffuse Large B Cell Lymphoma Patients

Laura Korin, MD, Santiago Cranco, MD, Maria Lucia Fuente, Paola Ochoa, MD, Adriana Vitriu, MD, Evelina Babuin, Maria Belen Venegas, Paula Tempra, Andrea Novoa, Anahí Vijnovich Baron, MD, Fernando Diaz Couselo, MD, Norma Elisabeth Tartas, MD, Maria Del Rosario Custidiano, MD, Maria Cecilia Foncuberta, MD, Julio Cesar Sanchez Avalos, MD

Blood (2020) 136 (Supplement 1): 23.

https://doi.org/10.1182/blood-2020-138881

Published: 2020

Journal Articles

Percentage of Infiltrating T Lymphocytes in Diffuse Large B-Cell Lymphoma Lymph Nodes Measured By Flow Cytometry Predicts Overall Survival and Provides Additional Prognostic Information When Combined with the R-IPI

Laura Korin, MD, Maria Del Rosario Custidiano, MD, Maria Lucia Fuente, Santiago Cranco, MD, Adriana Vitriu, MD, Paola Ochoa, MD, Evelina Babuin, Fernando Diaz Couselo, MD, Anahí Vijnovich Baron, MD, Paula Tempra, Maria Belen Venegas, Andrea Novoa, Norma Elisabeth Tartas, MD, Maria Cecilia Foncuberta, MD, Julio Cesar Sanchez Avalos, MD

Blood (2019) 134 (Supplement_1): 1625.

https://doi.org/10.1182/blood-2019-126193

Published: 2019

Journal Articles

Secondary Acute Myeloid Leukemia: Demographic, Physiopathogenic, Clinical and Therapeutic Comparative Study

Roberto Ovilla, MD, Renee Leonor Crisp, PhD, Pamela E Baez-Islas, MD, Jorge A Arbelbide, MD, Sofia Grille, MD PhD, Lilián Díaz, MD, Henry Idrobo, MD Professor, Alicia Enrico, MD, Maria J Mela Osorio, MD, Isolda I. Fernandez, MD, Luciana C Ferrari, MD, Nidia Zapata, MD, Adrian A Ceballos-Lopez, Veronica Mena, MD, Ana L Romero, MD, Juan Carlos Serrano, MD, Gabriela Vidal-Senmache, MD, Fernando Barroso Duarte, MD, Edit N Pintos, MD, Mariana Rosenhain, MD, Laura Kornblihtt, MD, Natalia Tejeira, MD, Breno Gusmao, MD, Maria Elena Del Rocio Buenaño, MD, Marcos Di Stefano, MD, Matilde Boada, MD, Alberto Gimenez Conca, MD, Maria Perusini, MD, Hernan Dick, MD, Santiago Cranco, MD, Maria Lucia Fuente, Alicia Beatriz Navickas, MD, Maria M Moirano, MD, Natalia Oliveira, MD, Jacqueline Gonzalez, MD, Mariana Bandín, MD, Noelia Villaverde, MD, Alejandro Suero, MD, Juan Felipe Lasso, MD, Nora Carrara, MD, Xochitl Cota, MD, Carolina Lazzarino, MD, Maria Leticia Rapan, MD, Marcelo Iastrebner, MD, Latin-American MDS Group (GLAM), MDS and Acute Leukemia Sub-Commission Group Argentinian Society of Hematology

Blood (2019) 134 (Supplement_1): 5096.

https://doi.org/10.1182/blood-2019-125311

Published: 2019

Journal Articles

Induction Treatment and Feasibility of Allogeneic Hematopoietic Stem Cell Transplantation in Young Patients (<65 years) with High-Risk Cytogenetic and Secondary Acute Myeloid Leukemia (AML): A Single Center Experience in Argentina with CLAG-M and 7+3

Maria Lucia Fuente, Maria Del Rosario Custidiano, MD, Santiago Cranco, MD, Laura Korin, MD, Paola Ochoa, MD, Adriana Vitriu, MD, Evelina Babuin, Andrea Novoa, Paula Tempra, Maria Belen Venegas, Fernando Diaz Couselo, MD, Norma Elisabeth Tartas, MD, Julio Cesar Sanchez Avalos, MD, Maria Cecilia Foncuberta, MD

Blood (2019) 134 (Supplement_1): 5132.

https://doi.org/10.1182/blood-2019-128491

Published: 2019

NARROW

Microenvironment Immune Cells in Bone Marrow and Lymph Node Measured By Flow Cytometry Have Prognostic Impact on Survival in Nodal Non-Hodgkin T-Cell Lymphoma

Low Percentage of Microenvironment Immune Cells in Bone Marrow and Lymph Node Measured By Flow Cytometry Is Associated with Inferior Overall Survival in Diffuse Large B Cell Lymphoma

Bone Marrow Microenvironment Immune Cells Measured By Flow Cytometry Can Predict Survival and Identify a Subgroup in Risk of Early Relapse in Diffuse Large B Cell Lymphoma Patients

Percentage of Infiltrating T Lymphocytes in Diffuse Large B-Cell Lymphoma Lymph Nodes Measured By Flow Cytometry Predicts Overall Survival and Provides Additional Prognostic Information When Combined with the R-IPI

Secondary Acute Myeloid Leukemia: Demographic, Physiopathogenic, Clinical and Therapeutic Comparative Study

Induction Treatment and Feasibility of Allogeneic Hematopoietic Stem Cell Transplantation in Young Patients (<65 years) with High-Risk Cytogenetic and Secondary Acute Myeloid Leukemia (AML): A Single Center Experience in Argentina with CLAG-M and 7+3

Email alerts

ASH Publications

American Society of Hematology

Microenvironment Immune Cells in Bone Marrow and Lymph Node Measured By Flow Cytometry Have Prognostic Impact on Survival in Nodal Non-Hodgkin T-Cell Lymphoma

Low Percentage of Microenvironment Immune Cells in Bone Marrow and Lymph Node Measured By Flow Cytometry Is Associated with Inferior Overall Survival in Diffuse Large B Cell Lymphoma

Bone Marrow Microenvironment Immune Cells Measured By Flow Cytometry Can Predict Survival and Identify a Subgroup in Risk of Early Relapse in Diffuse Large B Cell Lymphoma Patients

Percentage of Infiltrating T Lymphocytes in Diffuse Large B-Cell Lymphoma Lymph Nodes Measured By Flow Cytometry Predicts Overall Survival and Provides Additional Prognostic Information When Combined with the R-IPI

Secondary Acute Myeloid Leukemia: Demographic, Physiopathogenic, Clinical and Therapeutic Comparative Study

Induction Treatment and Feasibility of Allogeneic Hematopoietic Stem Cell Transplantation in Young Patients (<65 years) with High-Risk Cytogenetic and Secondary Acute Myeloid Leukemia (AML): A Single Center Experience in Argentina with CLAG-M and 7+3

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only